Merck To Stop Producing Dyslipidemia Drug Tredaptive
Merck has just announced plans to stop producing the extended-release niacin/laropiprant drug TREDAPTIVE. The drug, used to manage dyslipidemia, is
Source: Health News
Posted in: AICHC News
Leave a Comment (0) ↓